Evidence map›Paper›PMID 40140800›Full record

ArticleBMC endocrine disorders2025

Association of the inflammatory burden index with the risk of pre-diabetes and diabetes mellitus: a cross-sectional study.

Shuo Yu, Jiaxin Li, He Chen, Fuyu Xue, Siyi Wang, Meihui Tian, Hongfeng Wang, Haipeng Huang, Mengyuan Li

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Foods (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuo YuChangchun University of Traditional Chinese Medicine, Changchun, Jilin, China.
Jiaxin LiChangchun University of Traditional Chinese Medicine, Changchun, Jilin, China.
He ChenJilin Engineering Vocational College, Siping, Jilin, China.
Fuyu XueThe Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
Siyi WangChangchun University of Traditional Chinese Medicine, Changchun, Jilin, China.
Meihui TianChangchun University of Traditional Chinese Medicine, Changchun, Jilin, China.
Hongfeng WangChangchun University of Traditional Chinese Medicine, Changchun, Jilin, China. zyywtg@163.com.
Haipeng HuangChangchun University of Traditional Chinese Medicine, Changchun, Jilin, China. hhp246@126.com.
Mengyuan LiChangchun University of Traditional Chinese Medicine, Changchun, Jilin, China. lmylixiaoquan@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to investigate the association between the Inflammatory Burden Index (IBI) and the prevalence of pre-diabetes (pre-DM) and diabetes mellitus (DM) in the U.S. population from 1999 to 2010. By analyzing relevant data collected during this period, the study seeks to understand IBI's role in the onset of pre-DM and DM and its potential implications for public health.

methodsA cross-sectional analysis was conducted using data from the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2010. A total of 29,554 participants were included, with diabetes status determined by self-reported diagnoses and clinical indicators (such as glycosylated hemoglobin and fasting blood glucose). The Inflammatory Burden Index (IBI) was calculated using C-reactive protein (CRP) multiplied by the neutrophil-to-lymphocyte ratio. The generalized additive model (GAM) was employed to examine the relationship between increasing IBI and the incidence of pre-DM and DM.

resultThe study included 29,554 participants, with 14,290 (48.4%) men and 15,264 (51.6%) women, and a mean age of 48.3 years (SD = 19.1). The findings revealed a significant association between IBI and the risk of pre-DM and DM. In the fully adjusted model, a stronger relationship was observed between pre-DM, DM, and IBI. The prevalence of pre-DM and DM was significantly higher in the fourth quartile (Q4) compared to the first quartile (Q1), with a 26% prevalence of pre-DM and an 18% prevalence of DM when IBI was greater than 1.04.

conclusionOur study demonstrates a significant correlation between IBI and the risk of pre-DM and DM in the U.S. POPULATION: Given these findings, we recommend that IBI be considered as a key indicator for the management and treatment of pre-DM and DM in clinical settings.

Indexed as

BiomarkersDiabetes MellitusInflammationPrediabetic StateAdultAgedC-Reactive ProteinCross-Sectional StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedNutrition SurveysPrevalencePrognosisBiomarkersC-Reactive ProteinCross-sectional studyDiabetes mellitusIBINHANESPre-diabetesRelevance analysis

Identifiers

PMID40140800
PMCPMC11938584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.